
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 10 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Develop and execute strategic account plans across health systems, IDNs, and treatment centers. • Lead treatment center activation, onboarding, contracting, operational readiness, and site certification. • Serve as the primary customer contact for CAR-T/cell therapy operations, logistics, and order management. • Partner cross-functionally with Sales, Marketing, Medical Affairs, Market Access, Patient Services, Supply Chain, Manufacturing, Quality, Finance, Legal, and Commercial Operations to resolve issues and deliver key performance indicators. • Support reimbursement strategies, and contracting initiatives. • Drive expansion initiatives including satellite apheresis, outpatient treatment models, and multi-site frameworks. • Analyze and monitor account performance, identify operational gaps, and implement continuous improvements. • Represent customer insights, site performance and launch readiness in senior level meetings. • Build executive relationships and lead strategic business reviews.
• Bachelor's degree required; advanced degree preferred. • 8+ years of biotechnology, pharmaceutical, cell therapy experience and proven site onboarding success. • Additional commercial experience with specialty biologics and neurology products a plus. • Experience managing health systems, IDNs, or treatment center accounts. • Knowledge of cell therapy operations, reimbursement, contracting, and GPOs. • Experience working cross-functionally within commercial and medical organizations. • Strong communication, analytical, negotiation, and executive relationship management skills.
• Bonus • Benefits • Participation in the Company's stock plan
Apply Now🔥 3 hours ago
Sr Director IT Business Enablement responsible for technology roadmaps and strategic alignment for Cytiva Manufacturing & Quality. Leading initiatives for operational excellence and innovation throughout enterprise IT.
🔥 4 hours ago
Senior Director Market Access leading payer engagement and market access strategies for diagnostics. Collaborating with medical and clinical teams to enhance reimbursement and reduce barriers in care.
🇺🇸 United States – Remote
💵 $180k - $210k / year
💰 Post-IPO Debt on 2019-06
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🔥 4 hours ago
Senior Director leading national and regional market access strategies at Labcorp. Collaborating across teams to secure payer engagement and reimbursement within Women’s Health & Reproductive Genetics.
🇺🇸 United States – Remote
💵 $180k - $210k / year
💰 Post-IPO Debt on 2019-06
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🔥 5 hours ago
Lead Director for Healthcare Quality Management overseeing quality strategies for Louisiana Medicaid populations. Responsible for execution of quality management initiatives and regulatory compliance at Aetna Better Health of Louisiana.
🔥 5 hours ago
Senior Director guiding platform delivery and operations for Epic applications in healthcare. Collaborating with stakeholders to enhance clinical outcomes and operational efficiency.